NEW YORK, Nov. 18 (GenomeWeb News) - Acacia Research subsidiary CombiMatrix said today that it has signed a Cooperative Research and Development Agreement (CRADA) with the US Army Medical Research Institute of Infectious Diseases (USAMRIID) to develop microarray technology for environmental and medical detection of biothreat agents.
Financial details of the CRADA were not disclosed.
Under the agreement, USAMRIID and CombiMatrix will share consultative services, equipment, reagents, and testing support to demonstrate the effectiveness of CombiMatrix's Electrochemical Detection System for identifying biothreat agents. USAMRIID will provide appropriate reagents to CombiMatrix during the project for live agent testing in USAMRIID's secure facilities.